» Articles » PMID: 31138994

Glutamine Supplementation Ameliorates Chronic Stress-induced Reductions in Glutamate and Glutamine Transporters in the Mouse Prefrontal Cortex

Overview
Journal Exp Neurobiol
Specialty Neurology
Date 2019 May 30
PMID 31138994
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic immobilization stress (CIS) induces low levels of glutamate (Glu) and glutamine (Gln) and hypoactive glutamatergic signaling in the mouse prefrontal cortex (PFC), which is closely related to the Glu-Gln cycle. A Gln-supplemented diet ameliorates CIS-induced deleterious changes. Here, we investigated the effects of CIS and Gln supplementation on Glu-Gln cycle-related proteins to characterize the underlying mechanisms. Using the CIS-induced depression mouse model, we examined the expression of 11 proteins involved in the Glu-Gln cycle in the PFC. CIS decreased levels of glutamate transporter 1 (GLT1) and sodium-coupled neutral amino acid transporter (SNAT) 1, SANT2, SNAT3, and SNAT5. Gln supplementation did not affect the non-stressed group but significantly increased GLT1 and SNATs of the stressed group. By immunohistochemical analysis, we confirmed that SNAT1 and SNAT2 were decreased in neurons and GLT1, SNAT3, and SNAT5 were decreased in astrocytes in the medial PFC of the stressed group, but Gln-supplemented diet ameliorated these decrements. Collectively, these results suggest that CIS may cause depressive-like behaviors by decreasing Glu and Gln transportation in the PFC and that a Gln-supplemented diet could prevent the deleterious effects of CIS.

Citing Articles

Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases.

Kang J, Kim H, Baek J, Song M, Park H, Jeong W Acta Pharmacol Sin. 2025; .

PMID: 39775502 DOI: 10.1038/s41401-024-01441-2.


Astroglial Dysfunctions in Mood Disorders and Rodent Stress Models: Consequences on Behavior and Potential as Treatment Target.

Bansal Y, Codeluppi S, Banasr M Int J Mol Sci. 2024; 25(12).

PMID: 38928062 PMC: 11204179. DOI: 10.3390/ijms25126357.


The Relationship between Post-Traumatic Stress Disorder Due to Brain Injury and Glutamate Intake: A Systematic Review.

Gruenbaum B, Zlotnik A, Oleshko A, Matalon F, Shiyntum H, Frenkel A Nutrients. 2024; 16(6).

PMID: 38542812 PMC: 10975349. DOI: 10.3390/nu16060901.


Alterations in Astrocytic Regulation of Excitation and Inhibition by Stress Exposure and in Severe Psychopathology.

Kaul D, Schwab S, Mechawar N, Ooi L, Matosin N J Neurosci. 2024; 42(36):6823-6834.

PMID: 38377014 PMC: 9463979. DOI: 10.1523/JNEUROSCI.2410-21.2022.


The Role of Glutamine Homeostasis in Emotional and Cognitive Functions.

Baek J, Park H, Kang H, Kim R, Kang J, Kim H Int J Mol Sci. 2024; 25(2).

PMID: 38279303 PMC: 10816396. DOI: 10.3390/ijms25021302.


References
1.
Danbolt N . Glutamate uptake. Prog Neurobiol. 2001; 65(1):1-105. DOI: 10.1016/s0301-0082(00)00067-8. View

2.
Miller K, Richards B, Kriebel R . Glutamine-, glutamine synthetase-, glutamate dehydrogenase- and pyruvate carboxylase-immunoreactivities in the rat dorsal root ganglion and peripheral nerve. Brain Res. 2002; 945(2):202-11. DOI: 10.1016/s0006-8993(02)02802-0. View

3.
Hertz L, Zielke H . Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004; 27(12):735-43. DOI: 10.1016/j.tins.2004.10.008. View

4.
Rothstein J, Patel S, Regan M, Haenggeli C, Huang Y, Bergles D . Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005; 433(7021):73-7. DOI: 10.1038/nature03180. View

5.
Choudary P, Molnar M, Evans S, Tomita H, Li J, Vawter M . Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A. 2005; 102(43):15653-8. PMC: 1257393. DOI: 10.1073/pnas.0507901102. View